Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

News Daily News

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Yael L. Maxwell

April 03, 2024

News Daily News

Class I Recall for 350,000 Medtronic Defibrillators: FDA

Michael O'Riordan

July 19, 2023

News Daily News

Generic Dabigatran Lots Pulled for Nitrosamine Impurity

Michael O'Riordan

March 28, 2023

News Daily News

Recall for Mislabeled Cartons of Amiodarone, Tranexamic Acid Injections: FDA

Shelley Wood

September 01, 2020

News Daily News

FDA: Class I Recall for Medtronic’s Pipeline Flex and Pipeline Flex With Shield Technology

Caitlin E. Cox

March 31, 2020

News Daily News

FDA: Abbott Recalls NC Trek RX and NC Traveler Coronary Catheters

Shelley Wood

February 24, 2020

News Daily News

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

Shelley Wood

February 14, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Shelley Wood

January 14, 2020

News Daily News

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

Yael L. Maxwell

December 06, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Daily News

FDA: Class I Recall for CentriMag Circulatory Support System Motor

Caitlin E. Cox

November 07, 2019

News Daily News

FDA: Class I Recall for IntraClude Intra-Aortic Occlusion Device

Shelley Wood

July 02, 2019

News Daily News

FDA Warns Healthcare Providers of Potential Rise in Death Rate With Impella RP

Caitlin E. Cox

February 04, 2019

News Daily News

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

Michael O'Riordan

January 17, 2019

News Daily News

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

L.A. McKeown

October 16, 2018

FDA Warns of Deaths, Stroke With Latest-Generation Total Artificial Heart

News Daily News

FDA Warns of Deaths, Stroke Due to Power System Problems With Total Artificial Heart System

Lucy Hicks

August 17, 2018

News Daily News

FDA Posts Outdated Alert for Sapien 3 Transapical Delivery System

Shelley Wood

January 11, 2018

News Daily News

FDA Warns of Rising Endoleak Rates After Endovascular Aneurysm Repair

L.A. McKeown

October 02, 2017

News Industry News

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

May 26, 2017

News Conference News ACC 2017

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Michael O'Riordan

March 18, 2017

Advertisement

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Class I Recall for 350,000 Medtronic Defibrillators: FDA

Generic Dabigatran Lots Pulled for Nitrosamine Impurity

Recall for Mislabeled Cartons of Amiodarone, Tranexamic Acid Injections: FDA

FDA: Class I Recall for Medtronic’s Pipeline Flex and Pipeline Flex With Shield Technology

FDA: Abbott Recalls NC Trek RX and NC Traveler Coronary Catheters

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

FDA Is Surveilling Heparin but Believes Defective Quality Unlikely

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

FDA: Class I Recall for CentriMag Circulatory Support System Motor

FDA: Class I Recall for IntraClude Intra-Aortic Occlusion Device

FDA Warns Healthcare Providers of Potential Rise in Death Rate With Impella RP

FDA Alerts Doctors to Potential Late Risks With Paclitaxel-Coated Balloons and Stents in PAD

FDA: All AFX Endovascular AAA Systems Now Under Class I Recall

FDA Warns of Deaths, Stroke Due to Power System Problems With Total Artificial Heart System

FDA Posts Outdated Alert for Sapien 3 Transapical Delivery System

FDA Warns of Rising Endoleak Rates After Endovascular Aneurysm Repair

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content